UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 168

Sortiert nach

A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para‐aminohippurate clearance in healthy subjects

British journal of clinical pharmacology, 2013-04, Vol.75 (4), p.990-996

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2010-01, Vol.54 (1), p.254-258

2010

Link zum Volltext

Verfügbarkeit prüfen

Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

Antimicrobial Agents and Chemotherapy, 2013-08, Vol.57 (8), p.3536-3546

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Food on the Pharmacokinetics of the Integrase Inhibitor Dolutegravir

Antimicrobial Agents and Chemotherapy, 2012-03, Vol.56 (3), p.1627-1629

2012

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir

Clinical infectious diseases, 2002-01, Vol.34 (2), p.234-238

2002

Link zum Volltext

Verfügbarkeit prüfen

Effects of Etravirine Alone and with Ritonavir-Boosted Protease Inhibitors on the Pharmacokinetics of Dolutegravir

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3517-3521

2011

Link zum Volltext

Verfügbarkeit prüfen

Interactions among Drugs for HIV and Opportunistic Infections

The New England journal of medicine, 2001-03, Vol.344 (13), p.984-996

2001

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma

Clinical infectious diseases, 2005-12, Vol.41 (12), p.1787-1793

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

The New England journal of medicine, 2021-12, Vol.385 (24), p.2219-2229

2021

Link zum Volltext

Verfügbarkeit prüfen

One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial

Journal of the American Academy of Dermatology, 2022-10, Vol.87 (4), p.800-806

2022

Link zum Volltext

Verfügbarkeit prüfen

ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1–Infected, Antiretroviral Therapy–Naive Subjects

Clinical infectious diseases, 2014-10, Vol.59 (7), p.1032-1037

2014

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis

Journal of investigative dermatology, 2021-07, Vol.141 (7), p.1847-1851

2021

Link zum Volltext

Verfügbarkeit prüfen

Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics

American journal of clinical dermatology, 2022-01, Vol.23 (1), p.83-91

2022

Link zum Volltext

Verfügbarkeit prüfen

Bioequivalence of a dolutegravir, abacavir, and lamivudine fixed-dose combination tablet and the effect of food

Journal of acquired immune deficiency syndromes (1999), 2014-08, Vol.66 (4), p.393

2014

Link zum Volltext

Verfügbarkeit prüfen

Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in Rabbits

Antimicrobial Agents and Chemotherapy, 2001-12, Vol.45 (12), p.3322-3327

2001

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic and Pharmacodynamic Modeling of Anidulafungin (LY303366): Reappraisal of Its Efficacy in Neutropenic Animal Models of Opportunistic Mycoses Using Optimal Plasma Sampling

Antimicrobial Agents and Chemotherapy, 2001-10, Vol.45 (10), p.2845-2855

2001

Link zum Volltext

Verfügbarkeit prüfen

Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis

Antimicrobial Agents and Chemotherapy, 2002-08, Vol.46 (8), p.2554-2563

2002

Link zum Volltext

Verfügbarkeit prüfen

Effect of fosamprenavir-ritonavir on the pharmacokinetics of dolutegravir in healthy subjects

Antimicrobial agents and chemotherapy, 2014-11, Vol.58 (11), p.6696-6700

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment

European journal of clinical pharmacology, 2014-01, Vol.70 (1), p.29-35

2014

Link zum Volltext

Verfügbarkeit prüfen

Diarrhea and Reduced Levels of Antiretroviral Drugs: Improvement with Glutamine or Alanyl-Glutamine in a Randomized Controlled Trial in Northeast Brazil

Clinical infectious diseases, 2004-06, Vol.38 (12), p.1764-1770

2004

Link zum Volltext

Verfügbarkeit prüfen

Indinavir concentrations and St John's wort

The Lancet (British edition), 2000-02, Vol.355 (9203), p.547-548

2000

Link zum Volltext

Verfügbarkeit prüfen

Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next‐generation HIV integrase inhibitor, S/GSK1349572

British journal of clinical pharmacology, 2011-07, Vol.72 (1), p.103-108

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers

Journal of antimicrobial chemotherapy, 2011-07, Vol.66 (7), p.1567-1572

2011

Link zum Volltext

Verfügbarkeit prüfen

A Proof-of-Concept Study of Short-Cycle Intermittent Antiretroviral Therapy with a Once-Daily Regimen of Didanosine, Lamivudine, and Efavirenz for the Treatment of Chronic HIV Infection

The Journal of infectious diseases, 2004-06, Vol.189 (11), p.1974-1982

2004

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol

The Annals of pharmacotherapy, 2015-07, Vol.49 (7), p.784

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(141)

Publikationsform

Artikel
(145)
Buchkapitel
(21)
Bücher
(2)

Sprache

Englisch
(168)
Japanisch
(16)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(106)
Science & Technology
(106)
Humans
(92)
Biological And Medical Sciences
(80)
Medical Sciences
(80)
Pharmacology. Drug Treatments
(71)
Pharmacology & Pharmacy
(69)
Female
(61)
Male
(58)
Adult
(53)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(45)
Infectious Diseases
(42)
Microbiology
(42)
Middle Aged
(40)
Aids/hiv
(34)
Drug Interactions
(27)
Hiv Infections - Drug Therapy
(25)
Human Immunodeficiency Virus
(25)
Pharmacology
(25)
Area Under Curve
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para‐aminohippurate clearance in healthy subjects

Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers

Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

Effect of Food on the Pharmacokinetics of the Integrase Inhibitor Dolutegravir

The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir

Effects of Etravirine Alone and with Ritonavir-Boosted Protease Inhibitors on the Pharmacokinetics of Dolutegravir

Interactions among Drugs for HIV and Opportunistic Infections

Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial

ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1–Infected, Antiretroviral Therapy–Naive Subjects

A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis

Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics

Bioequivalence of a dolutegravir, abacavir, and lamivudine fixed-dose combination tablet and the effect of food

Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in Rabbits

Pharmacokinetic and Pharmacodynamic Modeling of Anidulafungin (LY303366): Reappraisal of Its Efficacy in Neutropenic Animal Models of Opportunistic Mycoses Using Optimal Plasma Sampling

Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis

Effect of fosamprenavir-ritonavir on the pharmacokinetics of dolutegravir in healthy subjects

Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment

Diarrhea and Reduced Levels of Antiretroviral Drugs: Improvement with Glutamine or Alanyl-Glutamine in a Randomized Controlled Trial in Northeast Brazil

Indinavir concentrations and St John's wort

Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next‐generation HIV integrase inhibitor, S/GSK1349572

Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers

A Proof-of-Concept Study of Short-Cycle Intermittent Antiretroviral Therapy with a Once-Daily Regimen of Didanosine, Lamivudine, and Efavirenz for the Treatment of Chronic HIV Infection

Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol

Suchergebnisse filtern